Concepedia

Norbert Lotz

NL

5

Publications

184

Citations

5

H-Index

2005

Active since

Affiliations

Kempten University of Applied Sciences(Current)

Norbert Lotz is an author at Kempten University of Applied Sciences specializing in atherosclerosis, cardiovascular disease, and metabolic syndrome.

Top concepts

HealthMedicineEpidemiologyHealth PolicyPublic HealthAtherosclerosisMetabolic SyndromeCardiovascular DiseaseHematologyImmunology

Publications per year

2005–2019

5

Publications

5

Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET.

E. Fricke, Harald Fricke, R. Weise et al. · PubMed · 2005 · 85 citations

Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany

Franz Heigl, R Hettich, Norbert Lotz et al. · Atherosclerosis Supplements · 2015 · 57 citations

Metabolic Syndrome, Thrombosis, Health Policy +9

Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease

Franz Heigl, R Hettich, Norbert Lotz et al. · Clinical Research in Cardiology Supplements · 2015 · 18 citations · Full text

Progressive Cardiovascular Disease, Cardiometabolic Risk, Hyperlipidemia +20

Indication and Implementation of Lipidapheresis, Rheopheresis, or Immunoadsorption (Lessons learnt from Germany's largest apheresis center)

Franz Heigl, R Hettich, Norbert Lotz et al. · Atherosclerosis Supplements · 2009 · 12 citations

Medicine, Physiology, Immunology +4

Lipoprotein apheresis in Germany – Still more commonly indicated than implemented. How can patients in need access therapy?

Franz Heigl, Tobias Pflederer, Reinhard Klingel et al. · Atherosclerosis Supplements · 2019 · 12 citations · Full text

Rows per page

1–5 of 5